Evidence map›Paper›PMID 41778042›Full record

ArticleFrontiers in medicine2026

Case Report: Membranous/cytoplasmic Ki-67 staining and PAX8-GLIS3 fusion: defining the clinicopathological spectrum of hyalinizing trabecular tumor to optimize patient management.

Haining Huang, Ran Zhao, Liman Zhang, Shujun Ren, Jianli Liu, Dandan Yang, Junjun Zhang, Renya Zhang, Shuai Chen, Lei Li

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haining Huang *Department of Clinical Pharmacy, Affiliated Hospital of Jining Medical University, Jining, China.
Ran Zhao *Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Liman Zhang *Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Shujun RenDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Jianli LiuDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Dandan YangDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Junjun ZhangDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Renya ZhangDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Shuai ChenDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.
Lei LiDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyalinizing trabecular tumor (HTT) is a rare thyroid neoplasm with an excellent prognosis, yet its morphological resemblance to malignancies such as papillary thyroid carcinoma (PTC) often complicates its diagnosis. To characterize the clinicopathological, immunohistochemical, and molecular profiles of HTT, this study analyzed 21 HTT cases and 10 PTC cases, and the findings were supplemented by a literature review. The HTT cohort included 18 female and 3 male patients, with a mean age of 51 years. Cytologically, HTT can be distinguished from PTC by its distinctive membranous/cytoplasmic Ki-67 staining pattern and the presence of the

Indexed as

BRAFclinicopathological featurehyalinizing trabecular tumorKi-67papillary thyroid carcinomaPAX8-GLIS3 fusion

Identifiers

PMID41778042
PMCPMC12950578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.